Insulin efsitora alfa (investigational once-weekly basal insulin): In another ADA-sponsored symposium, Lilly will share results from the QWINT-1, QWINT-3 and QWINT-4 Phase 3 trials, which evaluated ...

Partner presentations reinforce ability of proprietary AzymetricTM platform to develop clinically validated therapeutic antibodies <li ...

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...

Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following ...

Explore Allogene's innovative CAR-T therapies targeting cancer & autoimmune diseases. ASCO updates on ALLO-316 could validate ...

E4 Computer Engineering will be among the protagonists at ISC High Performance, Europe’s benchmark event for supercomputing, ...

Teva's innovative portfolio continues to drive strong performance and future potential. The company has announced its target ...

Servier today announced that it will present updates from its research programs at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting on May 30 – June 3 in Chicago. Presentations ...

AbbVie Inc ABBV stock is trending on Tuesday after the U.S. drug giant announced that key data from its broad oncology ...

Discover how to turn photos into videos using AI with Media.io. Create dynamic visual content directly from your browser, no ...

Ongoing trade and macroeconomic uncertainties could create earnings headwinds for British American Tobacco and Philip Morris.

The banks include Citi, Goldman Sachs and Jefferies from the global banking consortium, alongside ICICI Securities and Axis Capital representing Indian financial institutions.